MyHep 400mg Tablet (Sofosbuvir)

Myhep 400mg Tablet contains the active component as Sofosbuvir. It is a direct-acting antiviral medication used to treat hepatitis C virus (HCV) infection. This medication is often combined with other antiviral drugs to form a regimen that can effectively eliminate HCV from the body. Myhep 400mg Tablet has significantly shortened the duration of HCV treatment compared to older therapies. It is effective against multiple genotypes of the hepatitis C virus. This broad-spectrum activity makes it a versatile treatment option that can be used for a wide range of patients infected with different HCV genotypes. 

Treatment of hepatitis C virus (HCV) infection

Myhep 400mg Tablet, a direct-acting antiviral medication, exerts a potent therapeutic effect in treating hepatitis C virus (HCV) infections. This medication disrupts the virus's ability to replicate and proliferate within the body by inhibiting the RNA polymerase enzyme necessary for HCV replication. When combined with other antiviral drugs, this targeted action leads to high cure rates, improved treatment outcomes, and shorter treatment durations

Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Myhep 400mg Tablet, reducing effectiveness by causing undesirable side effects

• Store the Ledifos Tablet at a controlled room temperature of (30°C).
• Keep it out of reach of children

Myhep 400mg Tablet is typically prescribed with other antiviral medications for treating hepatitis C (HCV) infection. This medication is usually taken orally once a day, with or without food. It is recommended to complete the full course of treatment as prescribed, even if symptoms improve, to ensure the best chance of achieving a sustained virologic response (SVR) and curing the HCV infection